DXCM Insider Transactions — Page 18
2,284 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1,701–1,800; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| GREGG TERRANCE H | CEO | 2014-11-26 | Sale | 34,990.0 | $51.15 |
| GREGG TERRANCE H | CEO | 2014-11-25 | Sale | 20,010.0 | $51.0 |
| Balo Andrew K | SVP, Regulatory and Clinical | 2014-11-25 | Sale | 10,000.0 | $51.11 |
| GREGG TERRANCE H | CEO | 2014-11-24 | Sale | 35,000.0 | $51.06 |
| DOUBLEDAY RICHARD | Sr. VP. Worldwide Sales | 2014-11-24 | Sale | 4,000.0 | $50.36 |
| DOUBLEDAY RICHARD | Sr. VP. Worldwide Sales | 2014-11-24 | Sale | 4,000.0 | $50.36 |
| Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | 2014-11-24 | Sale | 8,500.0 | $51.13 |
| Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | 2014-11-24 | Sale | 14,000.0 | $50.35 |
| GREGG TERRANCE H | CEO | 2014-11-21 | Sale | 10,000.0 | $50.5 |
| GREGG TERRANCE H | CEO | 2014-11-19 | Sale | 10,000.0 | $51.0 |
| GREGG TERRANCE H | CEO | 2014-11-17 | Sale | 10,000.0 | $52.52 |
| GREGG TERRANCE H | CEO | 2014-11-17 | Sale | 25,000.0 | $52.52 |
| GREGG TERRANCE H | CEO | 2014-11-14 | Sale | 10,000.0 | $52.51 |
| LISTER JOHN | Sr. VP, General Counsel | 2014-11-12 | Sale | 1,328.0 | $52.81 |
| LISTER JOHN | Sr. VP, General Counsel | 2014-11-12 | Sale | 1,750.0 | $52.82 |
| GREGG TERRANCE H | CEO | 2014-11-12 | Sale | 25,000.0 | $54.01 |
| GREGG TERRANCE H | CEO | 2014-11-11 | Sale | 55,000.0 | $53.06 |
| Balo Andrew K | SVP, Regulatory and Clinical | 2014-11-11 | Sale | 10,000.0 | $52.93 |
| ROPER JESS | VP, CFO | 2014-11-11 | Sale | 20,000.0 | $52.93 |
| MOY JEFFREY | SVP, Operations | 2014-11-11 | Sale | 4,000.0 | $53.0 |
| LORD JONATHAN T MD | Director | 2014-11-11 | Sale | 18,058.0 | $53.09 |
| VALDES JORGE A | CTO | 2014-11-10 | Sale | 16,000.0 | $51.23 |
| Balo Andrew K | SVP, Regulatory and Clinical | 2014-10-27 | Sale | 10,000.0 | $42.98 |
| DOUBLEDAY RICHARD | Sr. VP. Worldwide Sales | 2014-10-23 | Sale | 4,000.0 | $43.58 |
| Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | 2014-10-23 | Sale | 14,000.0 | $43.6 |
| ROPER JESS | VP, CFO | 2014-10-20 | Sale | 8,000.0 | $41.18 |
| GREGG TERRANCE H | CEO | 2014-10-15 | Sale | 10,000.0 | $39.63 |
| GREGG TERRANCE H | CEO | 2014-10-15 | Sale | 25,000.0 | $39.63 |
| LISTER JOHN | Sr. VP, General Counsel | 2014-10-13 | Sale | 1,650.0 | $40.42 |
| LISTER JOHN | Sr. VP, General Counsel | 2014-10-13 | Sale | 1,750.0 | $40.41 |
| Balo Andrew K | SVP, Regulatory and Clinical | 2014-10-13 | Sale | 10,000.0 | $40.42 |
| VALDES JORGE A | CTO | 2014-10-08 | Sale | 16,000.0 | $40.29 |
| Balo Andrew K | SVP, Regulatory and Clinical | 2014-09-25 | Sale | 10,000.0 | $40.71 |
| DOUBLEDAY RICHARD | Sr. VP. Worldwide Sales | 2014-09-23 | Sale | 4,000.0 | $40.32 |
| Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | 2014-09-23 | Sale | 14,000.0 | $40.32 |
| ROPER JESS | VP, CFO | 2014-09-18 | Sale | 2,500.0 | $41.91 |
| ROPER JESS | VP, CFO | 2014-09-18 | Sale | 5,500.0 | $41.91 |
| GREGG TERRANCE H | CEO | 2014-09-15 | Sale | 10,000.0 | $41.14 |
| GREGG TERRANCE H | CEO | 2014-09-15 | Sale | 25,000.0 | $41.14 |
| LISTER JOHN | Sr. VP, General Counsel | 2014-09-12 | Sale | 1,750.0 | $43.7 |
| LISTER JOHN | Sr. VP, General Counsel | 2014-09-12 | Sale | 1,768.0 | $43.7 |
| Balo Andrew K | SVP, Regulatory and Clinical | 2014-09-11 | Sale | 9,582.0 | $42.97 |
| Balo Andrew K | SVP, Regulatory and Clinical | 2014-09-11 | Sale | 418.0 | $42.97 |
| VALDES JORGE A | CTO | 2014-09-08 | Sale | 16,000.0 | $42.98 |
| KAHN BARBARA | Director | 2014-08-28 | Sale | 4,000.0 | $44.52 |
| LORD JONATHAN T MD | Director | 2014-08-26 | Sale | 20,000.0 | $45.56 |
| MOY JEFFREY | SVP, Operations | 2014-08-26 | Sale | 6,663.0 | $45.0 |
| MOY JEFFREY | SVP, Operations | 2014-08-26 | Sale | 10,000.0 | $45.5 |
| GREGG TERRANCE H | CEO | 2014-08-26 | Sale | 5,000.0 | $46.05 |
| Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | 2014-08-26 | Sale | 16,000.0 | $44.85 |
| Balo Andrew K | SVP, Regulatory and Clinical | 2014-08-25 | Sale | 10,000.0 | $44.12 |
| DOUBLEDAY RICHARD | Sr. VP. Worldwide Sales | 2014-08-25 | Sale | 4,000.0 | $44.35 |
| Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | 2014-08-25 | Sale | 14,000.0 | $44.24 |
| GREGG TERRANCE H | CEO | 2014-08-22 | Sale | 7,500.0 | $44.36 |
| GREGG TERRANCE H | CEO | 2014-08-22 | Sale | 6,107.0 | $44.58 |
| Balo Andrew K | SVP, Regulatory and Clinical | 2014-08-22 | Sale | 20,000.0 | $44.24 |
| VALDES JORGE A | CTO | 2014-08-21 | Sale | 10,671.0 | $43.58 |
| GREGG TERRANCE H | CEO | 2014-08-21 | Sale | 6,393.0 | $43.5 |
| KAHN BARBARA | Director | 2014-08-21 | Sale | 2,200.0 | $43.42 |
| GREGG TERRANCE H | CEO | 2014-08-20 | Sale | 17,500.0 | $44.67 |
| GREGG TERRANCE H | CEO | 2014-08-19 | Sale | 30,000.0 | $45.1 |
| GREGG TERRANCE H | CEO | 2014-08-19 | Sale | 10,000.0 | $45.09 |
| GREGG TERRANCE H | CEO | 2014-08-19 | Sale | 35,000.0 | $45.06 |
| DOUBLEDAY RICHARD | Sr. VP. Worldwide Sales | 2014-08-19 | Sale | 20,000.0 | $45.01 |
| GREGG TERRANCE H | CEO | 2014-08-18 | Sale | 10,000.0 | $44.04 |
| GREGG TERRANCE H | CEO | 2014-08-18 | Sale | 5,000.0 | $44.16 |
| GREGG TERRANCE H | CEO | 2014-08-18 | Sale | 15,000.0 | $44.18 |
| GREGG TERRANCE H | CEO | 2014-08-18 | Sale | 20,000.0 | $44.3 |
| GREGG TERRANCE H | CEO | 2014-08-18 | Sale | 25,000.0 | $44.04 |
| ROPER JESS | VP, CFO | 2014-08-18 | Sale | 1,247.0 | $43.95 |
| ROPER JESS | VP, CFO | 2014-08-18 | Sale | 6,753.0 | $43.95 |
| GREGG TERRANCE H | CEO | 2014-08-15 | Sale | 5,000.0 | $44.06 |
| GREGG TERRANCE H | CEO | 2014-08-14 | Sale | 20,000.0 | $44.23 |
| GREGG TERRANCE H | CEO | 2014-08-14 | Sale | 5,000.0 | $44.26 |
| GREGG TERRANCE H | CEO | 2014-08-13 | Sale | 9,999.0 | $44.06 |
| GREGG TERRANCE H | CEO | 2014-08-13 | Sale | 12,500.0 | $43.32 |
| GREGG TERRANCE H | CEO | 2014-08-13 | Sale | 16,108.0 | $43.98 |
| GREGG TERRANCE H | CEO | 2014-08-12 | Sale | 17,500.0 | $43.09 |
| LISTER JOHN | Sr. VP, General Counsel | 2014-08-12 | Sale | 1,750.0 | $43.68 |
| LISTER JOHN | Sr. VP, General Counsel | 2014-08-12 | Sale | 1,603.0 | $43.68 |
| SAYER KEVIN R | President & COO | 2014-08-11 | Sale | 20,000.0 | $43.82 |
| Balo Andrew K | SVP, Regulatory and Clinical | 2014-08-11 | Sale | 10,000.0 | $44.24 |
| VALDES JORGE A | CTO | 2014-08-08 | Sale | 16,000.0 | $43.56 |
| Balo Andrew K | SVP, Regulatory and Clinical | 2014-07-25 | Sale | 10,000.0 | $38.19 |
| DOUBLEDAY RICHARD | Sr. VP. Worldwide Sales | 2014-07-23 | Sale | 3,751.0 | $38.16 |
| DOUBLEDAY RICHARD | Sr. VP. Worldwide Sales | 2014-07-23 | Sale | 249.0 | $38.16 |
| Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | 2014-07-23 | Sale | 14,000.0 | $38.28 |
| ROPER JESS | VP, CFO | 2014-07-18 | Sale | 8,000.0 | $36.01 |
| GREGG TERRANCE H | CEO | 2014-07-15 | Sale | 10,000.0 | $36.66 |
| GREGG TERRANCE H | CEO | 2014-07-15 | Sale | 25,000.0 | $36.66 |
| LISTER JOHN | Sr. VP, General Counsel | 2014-07-14 | Sale | 1,750.0 | $36.59 |
| LISTER JOHN | Sr. VP, General Counsel | 2014-07-14 | Sale | 1,750.0 | $36.59 |
| Balo Andrew K | SVP, Regulatory and Clinical | 2014-07-11 | Sale | 10,000.0 | $35.93 |
| VALDES JORGE A | CTO | 2014-07-08 | Sale | 16,000.0 | $36.66 |
| SKYLER JAY S | Director | 2014-07-02 | Sale | 12,200.0 | $40.09 |
| SKYLER JAY S | Director | 2014-07-01 | Sale | 17,800.0 | $40.02 |
| Balo Andrew K | SVP, Regulatory and Clinical | 2014-06-25 | Sale | 10,000.0 | $40.6 |
| DOUBLEDAY RICHARD | Sr. VP. Worldwide Sales | 2014-06-23 | Sale | 4,000.0 | $40.98 |
| Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | 2014-06-23 | Sale | 6,562.0 | $41.02 |
| Pacelli Steven Robert | EVP, Strategy & Corp. Dev. | 2014-06-23 | Sale | 7,438.0 | $41.02 |